-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kg8tHb8FyR5gwqUrdEEDHlAPXPSstw/mGnFG+mbuPg/wK0oKBAi5pkg/L9gcWhqW igO9kQP1mBpsQEf4+o2GqA== 0001181431-04-018535.txt : 20040401 0001181431-04-018535.hdr.sgml : 20040401 20040401151618 ACCESSION NUMBER: 0001181431-04-018535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040123 FILED AS OF DATE: 20040401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019611992 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCNAY JOSEPH C CENTRAL INDEX KEY: 0001257674 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15070 FILM NUMBER: 04709349 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STE 700 STREET 2: C/O REGENERX BIOPHARMACEUTICALS INC CITY: BETHESDA STATE: MD ZIP: 20814 4 1 rrd38365.xml FORM 4 OF JOSEPH C. MCNAY (JANUARY 23, 2004) X0201 4 2004-01-23 0 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX.OB 0001257674 MCNAY JOSEPH C 3 BETHESDA METRO CENTER BETHESDA MD 20814 1 0 0 0 Common Stock 2004-01-23 4 P 0 105263 .95 A 1142795 D Options .28 2002-06-12 2012-06-12 Common Stock 100000 100000 D Options .53 1995-05-01 2005-05-01 Common Stock 5000 5000 D Class D Warrants .10 1997-03-12 2007-03-12 Common Stock 165000 165000 D Common Stock Warrant 1.50 2004-01-23 4 J 0 26316 0 A 2004-01-23 2006-07-23 Common Stock 26316 26316 D Options granted under the RegeneRx Biopharmaceuticals, Inc. 2000 Stock Option and Incentive Plan vest over four years in equal amounts beginning with the first anniversary of the date of grant (June 12, 2001). Options granted under the RegeneRx Biopharmaceuticals, Inc. Directors Stock Option Plan vested upon the date of grant (May 1, 1995). Warrant issued to the Reporting Person in consideration of the Reporting Person's purchase of common stock. /s/ Joseph C. McNay 2004-03-31 -----END PRIVACY-ENHANCED MESSAGE-----